EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH

Jakob Bolinder iD, Oskar Ragnarsson, Gudmundur Johansson

Clinical Endocrinology · 2026-09 · 105 (3) · 360-362

DOI: 10.1111/cen.70172 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Endocrinology, online erschienen am 18.06.2026. Verfasst von Jakob Bolinder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Management of congenital adrenal hyperplasia (CAH) remains a balancing act between androgen excess and glucocorticoid over-exposure. We performed a retrospective review of 58 adults with 21‐hydroxylase deficiency (21‐OHD) followed at the Department of Endocrinology at the Sahlgrenska University Hospital during the period 2020–2024. While the limited study size and retrospective design warrant cautious interpretation, the findings nonetheless point to important challenges in current practice

Autor:innen und Institutionen

  • Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Jakob Bolinder

Zitieren

APA

Bolinder, J., Ragnarsson, O., & Johansson, G. (2026). Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH. Clinical Endocrinology, 105(3), 360-362. https://doi.org/10.1111/cen.70172

Vancouver

Bolinder J, Ragnarsson O, Johansson G. Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH. Clinical Endocrinology. 2026;105(3):360-362. doi:10.1111/cen.70172

BibTeX
@article{Bolinder2026,
  author = {Bolinder, Jakob and Ragnarsson, Oskar and Johansson, Gudmundur},
  title = {Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH},
  journal = {Clinical Endocrinology},
  year = {2026},
  volume = {105},
  number = {3},
  pages = {360--362},
  doi = {10.1111/cen.70172}
}
Kostenlos starten →